Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,237,304 papers from all fields of science
Search
Sign In
Create Free Account
4-amino-2-methylquinoline
Known as:
4-AQ(A)
, 4-aminoquinaldine
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Aminoquinolines
Quinaldines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
4-Aminoquinaldine monohydrate polymorphism: Prediction and impurity aided discovery of a difficult to access stable form.
D. Braun
,
H. Oberacher
,
Kathrin Arnhard
,
M. Orlova
,
U. Griesser
CrysteEngComm
2016
Corpus ID: 33855485
Crystal structure prediction studies indicated the existence of an unknown high density monohydrate structure (Hy1B°) as global…
Expand
2012
2012
Synthesis, electrochemical, spectrophotometric and potentiometric studies of two azo-compounds derived from 4-amino-2-methylquinoline in ethanolic-aqueous buffered solutions
M. El-Attar
,
I. Ismail
,
M. Ghoneim
2012
Corpus ID: 36043051
Two azo-compounds, 2-methyl-4-(5-amino-2-hydroxy-phenylazo)-quinoline (2) and 2-methyl-4-(2-hydroxy-5-nitrophenylazo)-quinoline…
Expand
2012
2012
Synthesis and biological evaluation of new sulfonamide derivatives as potential anti-Trypanosoma cruzi agents.
V. Bocanegra-García
,
Juan C Villalobos-Rocha
,
+4 authors
G. Rivera
Medicinal chemistry
2012
Corpus ID: 33649544
Chagas disease continues to be one of the main parasitic diseases in Latin America. Despite the fact that it was discovered more…
Expand
2011
2011
Discovery of Safe and Orally Effective 4-Aminoquinaldine Analogues as Apoptotic Inducers with Activity against Experimental Visceral Leishmaniasis
Partha Palit
,
A. Hazra
,
+6 authors
N. Ali
Antimicrobial Agents and Chemotherapy
2011
Corpus ID: 20803166
ABSTRACT Novel antileishmanials are urgently required to overcome emergence of drug resistance, cytotoxic effects, and…
Expand
2010
2010
Evaluation of Diarylureas for Activity Against Plasmodium falciparum.
Yiqun Zhang
,
Marc O. Anderson
,
+16 authors
R. Guy
ACS Medicinal Chemistry Letters
2010
Corpus ID: 24000433
A library of diarylurea IGFR inhibitors was screened for activity against chloroquine-sensitive (3D7) and chloroquine-resistant…
Expand
2010
2010
Synthesis of aryl-heteroaryl ureas (AHUs) based on 4-aminoquinoline and their evaluation against the insulin-like growth factor receptor (IGF-1R).
W. Engen
,
T. E. O’Brien
,
+5 authors
Marc O. Anderson
Bioorganic & Medicinal Chemistry
2010
Corpus ID: 1258692
2005
2005
Modulation of Ca2+‐dependent and Ca2+‐independent miniature endplate potentials by phorbol ester and adenosine in frog
T. Searl
,
E. M. Silinsky
British Journal of Pharmacology
2005
Corpus ID: 23047468
1 Phorbol esters and adenosine modulate transmitter release from frog motor nerves through actions at separate sites downstream…
Expand
2004
2004
FTIR and FT-Raman Spectral Investigations on 4-Aminoquinaldine and 5-Aminoquinoline
N. Puviarasan
,
V. Arjunan
,
S. Mohan
2004
Corpus ID: 97568335
The FTIR spectra of 4-aminoquinaldine and 5-aminoquinoline were recorded in solid phase on a Bruker IFS 66V spectrometer in the…
Expand
2004
2004
A new synthetic approach of N-(4-amino-2-methylquinolin-6-yl)-2-(4-ethylphenoxymethyl)benzamide (JTC-801) and its analogues and their pharmacological evaluation as nociceptin receptor (NOP…
I. Sestili
,
A. Borioni
,
+5 authors
M. D. Del Giudice
European journal of medicinal chemistry
2004
Corpus ID: 34967222
1961
1961
THE ANTIBACTERIAL ACTIVITY OF NEW DERIVATIVES OF 4‐AMINOQUINOLINE AND 4‐AMINOQUINALDINE
D. Caldwell
,
W. A. Cox
,
P. D’arcy
,
L. R. Rowe
The Journal of pharmacy and pharmacology
1961
Corpus ID: 37632833
Two new series of N‐alkyl derivatives of 4‐aminoquinoline and 4‐aminoquinaldine are described. Compounds in both series show…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE